Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOMPERIDONE Cause Maternal exposure timing unspecified? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Maternal exposure timing unspecified have been filed in association with DOMPERIDONE. This represents 0.5% of all adverse event reports for DOMPERIDONE.

23
Reports of Maternal exposure timing unspecified with DOMPERIDONE
0.5%
of all DOMPERIDONE reports
23
Deaths
23
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From DOMPERIDONE?

Of the 23 reports, 23 (100.0%) resulted in death, 23 (100.0%) required hospitalization, and 23 (100.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOMPERIDONE. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does DOMPERIDONE Cause?

Off label use (1,156) Vomiting (918) Condition aggravated (902) Abdominal pain upper (898) Dyspnoea (859) Dizziness (858) Drug ineffective (850) Asthenia (835) Arthralgia (827) Fatigue (814)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which DOMPERIDONE Alternatives Have Lower Maternal exposure timing unspecified Risk?

DOMPERIDONE vs DOMPERIDONE\PANTOPRAZOLE DOMPERIDONE vs DONANEMAB-AZBT DOMPERIDONE vs DONEPEZIL DOMPERIDONE vs DONEPEZIL\DONEPEZIL DOMPERIDONE vs DONEPEZIL\MEMANTINE

Related Pages

DOMPERIDONE Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified DOMPERIDONE Demographics